StockWatch
·
Pharmaceuticals
Quarterly Result5 Nov 2026, 07:01 pm

Abbott India Declares Unaudited Q2 FY27 Results

AI Summary

Abbott India Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results at a meeting held on November 5, 2026. The company operates in a single segment, Pharmaceuticals. The limited review report from the statutory auditors, Walker Chandiok & Co. LLP, did not contain any qualifications.

Key Highlights

  • Unaudited financial results for Q2 FY27 declared.
  • Board of Directors approved the results on November 5, 2026.
  • Statutory auditors issued an unqualified limited review report.
  • Company operates solely in the Pharmaceuticals segment.
  • Results cover both the quarter and half-year ended September 30, 2026.